ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $629,000 | +13.7% | 63,827 | +25.1% | 0.00% | 0.0% |
| Q4 2020 | $553,000 | +23.4% | 51,001 | +17.2% | 0.00% | 0.0% |
| Q3 2020 | $448,000 | -70.8% | 43,501 | -40.8% | 0.00% | -50.0% |
| Q2 2020 | $1,535,000 | +116.5% | 73,501 | +1.3% | 0.00% | +100.0% |
| Q1 2020 | $709,000 | +8.9% | 72,538 | +28.3% | 0.00% | 0.0% |
| Q4 2019 | $651,000 | +98.5% | 56,550 | -6.1% | 0.00% | 0.0% |
| Q3 2019 | $328,000 | +88.5% | 60,250 | +312.7% | 0.00% | – |
| Q2 2019 | $174,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
| EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
| VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
| 683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
| AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
| JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
| TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
| Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |